Microglia and Autism Spectrum Disorder: Overview of Current Evidence and Novel Immunomodulatory Treatment Options
- Authors
- Kim, Jung Won; Hong, Ji Yeon; Bae, Seung Min
- Issue Date
- Aug-2018
- Publisher
- KOREAN COLL NEUROPSYCHOPHARMACOLOGY
- Keywords
- Autism spectrum disorder; Maternal immune activation; Microglia; Immunomodulatory therapy
- Citation
- CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, v.16, no.3, pp.246 - 252
- Journal Title
- CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE
- Volume
- 16
- Number
- 3
- Start Page
- 246
- End Page
- 252
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/3501
- DOI
- 10.9758/cpn.2018.16.3.246
- ISSN
- 1738-1088
- Abstract
- Autism spectrum disorder is a rapidly increasing heterogeneous neurodevelopmental syndrome, remarked by persistent deficit in social communication, and restricted, repetitive patterns of behavior and interest. Lately, maternal immune activation and micgroglial dysfunction in the developing brain have been gaining mounting evidence and leading to studies of various novel agents as potential treatment options. A few immunomodulatory treatment options-luteolin, minocycline, suramin, vitamin D, gut microbiota-are discussed in the current article, regarding the current understanding of their mechanisms and evidence for potential clinical use. More studies are warranted to understand their exact mechanisms of action and to verify efficacy and safety in human subjects.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/3501)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.